The Global Oncolytic Virus Therapies Market research study published by Emergen Research is an extensive collection of insightful information about the Oncolytic Virus Therapies industry. The report covers the Oncolytic Virus Therapies Market segmentation along with a detailed outline of the Oncolytic Virus Therapies market size with regards to volume and valuation. The global oncolytic virus therapies market size is expected to reach USD 609.7 Million at a steady CAGR of 26.2% in 2028, according to latest analysis by Emergen Research. Rise in prevalence of cancer, increase in number of clinical trials and investment in research development for cancer therapies are driving the growth of oncolytic virus therapies market.
Oncolytic virus is a virus which infects and kills cancer cells and as these cancer cells are destroyed by oncolytic, they release new infectious particles which destroy remaining tumor. Cancer mortality rate is 158.3 per 100,000 people per year. Estimated national expense for cancer in the U.S. was USD 150.8 billion in 2018. This cost is likely to increase as population ages and need for development of new effective therapies will fuel oncolytic virus therapies market growth. The report provides comprehensive coverage of the Oncolytic Virus Therapies market scenario for the current period and forecast timeline of 2021-2028. The Oncolytic Virus Therapies market report contains an in-depth analysis of the historical, current, and projected revenues for every industry vertical, segment, end-use industries, applications, and regions.
Get a sample of the report @ https://www.emergenresearch.com/request-sample/704
The report further sheds light on the emerging growth opportunities, challenges, market threats, limitations, and factors likely to restrict the growth of the Oncolytic Virus Therapies market. The report further discusses in detail the market in international waters and the emerging trends in those regions. It also offers insights into the competitive landscape, market drivers, industrial scenario, and the latest product and technological developments to offer a comprehensive overview of the Oncolytic Virus Therapies market landscape.
The Oncolytic Virus Therapies research report also includes an insightful study of the prominent players of the industry along with their business overview, strategic planning, and business expansion plans adopted by them. This assists the readers and business owners in formulating strategic expansion and investment plans. The report focuses on mergers and acquisitions, joint ventures, collaborations, partnerships, corporate and government deals, and others. The report also talks about the expansions these prominent players are vying for in the key regions of the market. The report focuses on the detailed analysis of the technological and product developments undertaken by these companies.
The key companies studied in the report are:
- Oncolytics Biotech, Inc.,
- Amgen Inc.,
- Sorrento Therapeutics, Inc.,
- Transgene SA,
- Daiichi Sankyo Company, Limited,
- Shanghai Sunway Biotech Co., Ltd.,
- Takara Bio Inc.,
- PsiOxus Therapeutics,
- SillaJen, Inc., and
- ViroCure
On the basis of regional analysis, the market is segmented into the following regions: North America, Latin America, Europe, Asia Pacific, and Middle East Africa. The market is expected to be dominated by North American nations closely followed by European countries. Asia Pacific is expected to show a significant growth owing to recent advancements and rising investments in the RD sector.
To know more about the report, click @ https://www.emergenresearch.com/industry-report/oncolytic-virus-therapies-market
North America accounted for the largest revenue share in 2020. The U.S. is the primary contributor and is expected to witness high growth due to the large amount of funding by the private firms and government for clinical trials. Other factors driving the oncolytic virus therapies market are an increase in research and development initiatives to develop therapeutic options for chronic diseases, easy approval for clinical trials, and availability of highly sophisticated research infrastructure.
Emergen Research has segmented the global oncolytic virus therapies market on the basis of virus type, application, end-use, and region:
Virus Type Outlook (Revenue, USD Million; 2018–2028)
- Genetically Engineered Oncolytic Viruses
- Herpes Simplex Virus
- Adenovirus
- Vaccinia Virus
- Oncolytic Wild-Type Viruses
- Reovirus
- Newcastle Disease Virus
- Vesicular Stomatitis Virus
Application Outlook (Revenue, USD Million; 2018–2028)
- Solid Tumors
- Breast Cancer
- Prostate Cancer
- Lung Cancer
- Glioblastoma
- Melanoma
- Hematological Malignancies
- Lymphoma
- Leukemia
- Myeloma
End-use Outlook (Revenue, USD Million; 2018–2028)
- Hospitals
- Specialty Clinics
- Cancer Research Institute
The report addresses the following key points:
- The report estimates the expected market size from 2020-2027
- The report provides a forecast of market drivers, restraints, and future opportunities for the Oncolytic Virus Therapies market
- The report further analyses the changing market dynamics
- Regional analysis and segmentation of the market with analysis of the regions and segments expected to dominate the market growth
- Extensive competitive landscape mapping with profiles of the key competitors
- In-depth analysis of business strategies and collaborations such as mergers and acquisitions adopted by the key companies
- Revenue forecast, country scope, application insights, and product insights
Request customization of the report @ https://www.emergenresearch.com/request-for-customization/704
Thank you for reading our report. For any specific details on customization of this report, please get in touch with us. We will ensure the report you get is well-suited to your needs.
To know more about the Emergen Research reports
About Us:
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: [email protected]
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services
